- Others
- Thursday, 28 Nov 2019
Saudi Aramco plans to sell 1.5% of the company at an indicative price range of 30 riyals to 32 riyals
The retail portion of Saudi Aramco’s initial public offering (IPO) has been fully covered, with orders reaching 32.57 billion Saudi riyals (£6.77 billion), lead manager Samba Capital said on Wednesday.
The state-owned oil giant plans to sell 1.5% of the company, or about 3 billion shares, at an indicative price range of 30 riyals to 32 riyals, valuing the IPO at as much as 96 billion riyals ($25.6 billion) and giving the company a market value of between $1.6 trillion and $1.7 trillion.
Aramco has said at least one-third of the sale is expected to be covered by retail investors, who have until Nov. 28 to sign up.
Around 3.72 million retail investors had subscribed to 1.017 billion shares by 20:00 (1700 GMT) on Nov. 27, the statement said.
The IPO is the centrepiece of Crown Prince Mohammed bin Salman’s plans to diversify the Saudi economy away from its reliance on oil.
Related Industry Updates
Noteworthy Growth of North America Feminine Hygiene Products Market in 2027 by BASF SE,Biolchim S.p.A.,DowDuPont Inc.,Isagro S.p.A.,Koppert Biologicals Systems,Syngenta,UPL,Valent BioSciences LLC
Oct 13, 2020
Bottled Water Market 2025 Growth Opportunities, Top Key Players, Industry Outlook and Forecasts
Apr 20, 2021
Prepared Food Equipment Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast to 2020-2027
Apr 20, 2021
Teeth Whitening Market with COVID-19 Impact and Recovery Analysis Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast 2027
Apr 19, 2021
North America Biopharmaceutical Contract Manufacturing Market 2020-2027| Types, Applications, Regional Analysis and Key Companies Involved are Lonza Group, Abbvie Inc,WuXi Biologics, Thermo Fisher Scientific
Oct 20, 2020
Feminine hygiene Products More than Just a Part of Modern lifestyle
May 28, 2020
North America Biopharmaceutical Contract Manufacturing Market 2020-2027| Types, Applications, Regional Analysis and Key Companies Involved are Lonza Group, Abbvie Inc,WuXi Biologics, Thermo Fisher Scientific
Dec 10, 2020
Follow us on
